Results 1 to 10 of about 392,122 (247)

Dexamethasone may affect the occurrence of parenteral nutrition-associated cholestasis in preterm neonates [PDF]

open access: yesFrontiers in Pediatrics, 2022
IntroductionGlucocorticoids are currently used for the co-therapeutic management of autoimmune hepatitis and some cholestatic diseases. Thus far, we do not know the efficacy of glucocorticoids in the treatment of parenteral nutrition-associated ...
Saizhi Jiang, Qingqing Hu, Jing Zhang
doaj   +3 more sources

Total Parenteral Nutrition Treatment in a Diabetic Pregnant Woman Complicated with Hyperemesis Gravidarum, Malnutrition, and Intrauterine Growth Restriction [PDF]

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2004
Objective: We report a case of a pregnant woman with diabetes, complicated with hyperemesis gravidarum, malnutrition, and intrauterine growth restriction, who was treated beneficially with total parenteral nutrition.
Chih-Wei Chen   +3 more
doaj   +3 more sources

Successful management of chylous ascites with total parenteral nutrition and octreotide in children

open access: yesNutrición Hospitalaria, 2013
Purpose: To evaluate the effects of total parenteral nutrition and octreotide on pediatric patients with chylous ascites post-operative. Methods: Four patients were diagnosed with chylous ascites from nov 2009 to nov 2012.
Chao Yang   +5 more
doaj   +2 more sources

Total parenteral nutrition-associated cholestasis and risk factors in preterm infants

open access: yesThe Saudi Journal of Gastroenterology, 2014
Background/Aim: Development of hepatic dysfunction is a well-recognized complication of total parenteral nutrition in preterm infants. Previous studies reported the incidence of total parenteral nutrition-associated cholestasis and described possible ...
Turki M Alkharfy   +4 more
doaj   +2 more sources

Quality assessment of total parenteral nutrition admixtures by the use of fractional factorial design [PDF]

open access: yesVojnosanitetski Pregled, 2013
Background/Aim. Parenteral nutrition as a specific aspect of providing nutritients still remains a permanent topic of both theoretical and experimental research.
Mirković Dušica   +2 more
doaj   +4 more sources

Clinical impact of lipid injectable emulsion in internal medicine inpatients exclusively receiving parenteral nutrition: a propensity score matching analysis from a Japanese medical claims database [PDF]

open access: yesBMC Medicine, 2022
Background Although guidelines recommend lipid injectable emulsions (ILEs) be used as a part of parenteral nutrition, many patients in Japan receive lipid-free parenteral nutrition.
Kosei Takagi   +3 more
doaj   +2 more sources

Controversies in the Mechanism of Total Parenteral Nutrition Induced Pathology

open access: yesChildren, 2015
Over 30,000 patients are permanently dependent on Total Parenteral Nutrition (TPN) for survival with several folds higher requiring TPN for a prolonged duration. Unfortunately, it can cause potentially fatal complications.
Jain Ajay Kumar, Jeffery H. Teckman
doaj   +2 more sources

A systematic review about prophylactic L-carnitine administration in parenteral nutrition of extremely preterm infants [PDF]

open access: yesFarmacia Hospitalaria, 2018
: Objective: Preterm infants with total parenteral nutrition are at particular risk of developing carnitine deficiency with impaired tolerance of parenteral lipids.
Alba Salguero Olid   +2 more
doaj   +3 more sources

Treatment of enterocutaneous fistula with total parenteral nutrition in combination with octreotide: a case report [PDF]

open access: yesLiječnički vjesnik, 2023
Octreotide is an analog of the polypeptide hormone somatostatin, which can reduce gastrointestinal, biliary and pancreas secretion, as well as decrease gastrointestinal motility.
Antonia Alfirević   +3 more
doaj   +2 more sources

An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2nd or higher line chemotherapy regarding clinical benefit - PANUSCO [PDF]

open access: yesBMC Cancer, 2009
Background Pancreatic cancer is an extremely aggressive malignancy. Subjects are afflicted with a variety of disconcerting symptoms, including profound cachexia. Recent data indicate that the outcome of oncological patients suffering from cancer cachexia
Rötzer Ingeborg   +9 more
doaj   +4 more sources

Home - About - Disclaimer - Privacy